Advertisement

World Journal of Surgery

, Volume 23, Issue 2, pp 109–114 | Cite as

World Survey on the Complications of Hepatic and Prostate Cryotherapy

  • Joachim K. Seifert
  • David L. Morris

n

= 299) of whom we were aware. We requested information on the number of patients treated, the occurrence, and the clinical features of cryoshock and mortality and morbidity following cryotherapy of the prostate or liver. Altogether 134 completed questionnaires were returned (44.8%). Seventy-two centers had experience with hepatic cryotherapy and 62 with prostate cryotherapy. Following hepatic cryotherapy, the phenomenon of cryoshock was observed in 21 of 2173 patients (1%) and was responsible for 6 of 33 perioperative deaths (18.2%). Cryoshock was rare following prostate cryotherapy (2 of 5432 patients, 0.04%) and did not contribute to the overall mortality of 0.06%. Hepatic and prostate cryotherapy are safe. Cryoshock is rare after prostate cryotherapy but occurs in 1% of patients following hepatic cryotherapy. Cryoshock is associated with a high risk of death, being responsible for 18.2% of deaths in this survey. Research regarding the mechanism and possible avoidance of cryoshock is required.

Keywords

High Risk World Survey Hepatic Cryotherapy Prostate Cryotherapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Société Internationale de Chirugie 1999

Authors and Affiliations

  • Joachim K. Seifert
    • 1
  • David L. Morris
    • 1
  1. 1.Department of Surgery, University of New South Wales, The St. George Hospital, Kogarah, Sydney, New South Wales 2217, AustraliaAU

Personalised recommendations